Earnings Update: Here's Why Analysts Just Lifted Their Indegene Limited (NSE:INDGN) Price Target To ₹660
NiveshIQ
NSE: INDGN · Healthcare
Indegene Ltd.
₹619.40▲ ₹32.60 (+5.56%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on INDGN. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Indegene Ltd.
Indegene Limited is a digital-first life sciences commercialization firm headquartered in Bengaluru, operating across India, the US, Europe, and North America. Its core business is AI‑embedded commercialization services for biopharmaceuticals, emerging biotech, and medical devices, delivered through Enterprise Medical Solutions, Enterprise Commercial Solutions, and Other segments. In Q2 FY27, revenue surged 39.55% YoY to ₹1,122.30 Cr, while PAT rose to ₹112.30 Cr, reflecting strong demand for its omnichannel activation and analytics platforms. The company’s NEXT technology platform and regulatory‑safety services underpin a diversified revenue mix, with enterprise commercial solutions contributing the largest share. Indegene maintains a competitive edge by combining deep clinical expertise
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹2,590 Cr +309.80% | ₹2,839 Cr +9.64% | ₹3,510 Cr +23.64% |
| EBITDA Margin | 19.52% | 18.82% | 17.63% |
| Net Profit | ₹344.60 Cr +587.80% | ₹406.70 Cr +18.02% | ₹401.10 Cr -1.38% |
| EPS | ₹15.19 | ₹17.15 | ₹16.72 |
Annual figures in Indian Rupees (Crores). Source: company filings (NSE).
Recent News
Indegene INDGN Q2 FY27 Financial Results Newspaper Ad
Indegene Ltd (NSE:INDGN) (Q2 2027) Earnings Call Highlights: 39. ...
🔒
+ 3 more stories about Indegene Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q2FY27 results: revenue ₹1, 122 Cr, PAT ₹112 Cr, EPS ₹4.67, EBITDA margin 16.5%. Growth context: revenue YoY +39.6%, PAT YoY +10.0%, revenue QoQ +5.6%, PAT QoQ -3.4%.
Management commentary points to product launches, approvals, and therapy-mix improvement and new capacity addition and c...
FY26 (last completed FY): revenue ₹3, 510 Cr, PAT ₹401 Cr, EBITDA margin 17.6%, EPS ₹16.72. Year-on-year: revenue YoY +2...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantMore Healthcare stocks
Everything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for INDGN
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track INDGN alongside your other holdings
Unlock full INDGN research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Indegene Ltd.?
NiveshIQ detects active intelligence signals for Indegene Ltd. (INDGN) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Indegene Ltd.?
Indegene Ltd. operates in the Healthcare sector with a market capitalisation of ₹1,273,680.8L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.